Inferior wall MI

Reading File

Finding Sources

Searching PubMed

"inferior myocardial infarction"[MeSH Terms] AND management

Reading File

Finding Sources

Reading File

Loading Image

Finding Sources

Reading File

I now have comprehensive information from multiple authoritative textbooks. Let me compile the full answer.

Inferior Wall MI (Inferior STEMI)

Anatomy and Culprit Vessel

The inferior wall of the left ventricle and the AV node are supplied by the right coronary artery (RCA) in ~90% of cases (right-dominant circulation). In the remaining 10% (left-dominant), the left circumflex artery (LCx) serves this territory.

RCA occlusion (most common) - ST elevation is greater in lead III than lead II; ST depression in aVL and I; may have ST elevation in V1 suggesting RV involvement
LCx occlusion - ST elevation equal in II and III, or greater in II; aVL may be isoelectric or elevated; often "ECG-occult" on standard 12-lead
ROSEN's Emergency Medicine, p. 1005

ECG Findings

Diagnostic criteria: ST elevation ≥1 mm in 2 or more contiguous inferior leads: II, III, and aVF

Feature	Detail
ST elevation	Leads II, III, aVF
Reciprocal ST depression	Best seen in lead aVL (150° from lead III); also lead I; precordial leads V1-V3
III > II elevation	Suggests RCA occlusion (90% sensitive, 71% specific)
ST elevation in V1 (with inferior STEMI)	Suggests concomitant RV infarction
Q waves	Often disappear over time with inferior MI (unlike anterior MI where they persist)
ST resolution	Usually complete within 2 weeks

Reciprocal changes in inferior STEMI are associated with larger infarct size, greater cardiovascular adverse events, and higher mortality.

ROSEN's Emergency Medicine, pp. 1005-1006
Goldman-Cecil Medicine, p. 3395

Right Ventricular (RV) Infarction

Occurs in ~30% of inferior MIs when the RCA occludes proximal to the acute marginal branch.

Classic clinical triad:

Hypotension
Elevated JVP (clear lung fields)
Inferior STEMI on ECG

Kussmaul sign (JVP distension on inspiration) is relatively specific.

ECG diagnosis: ST elevation ≥1 mm in right precordial leads V4R-V6R (sensitivity/specificity >90%). Best window is within the first 24 hours (changes may resolve quickly). ST elevation in V1 with inferior STEMI is a screening clue.

Hemodynamic criteria: Right atrial pressure ≥10 mmHg AND ≥80% of pulmonary capillary wedge pressure.

RV infarction patients have 10-15% classic hemodynamic presentation, but this subgroup carries 25-30% in-hospital mortality vs <6% for inferior MI without RV involvement.

Goldman-Cecil Medicine, pp. 3854-3856

Key management differences for RV infarction:

Action	Rationale
IV fluid loading (normal saline 0.5-1L)	Maintain RV preload
AVOID nitrates	Can precipitate severe hypotension
AVOID diuretics	Same reason
Dobutamine (2-20 mcg/kg/min)	If output fails to improve after fluids
Restore AV synchrony (pacing if needed)	High-grade AV block is common; AV sequential pacing improves CO substantially
Prompt cardioversion if AF develops	AF occurs in ~1/3 of RV infarcts, causes severe hemodynamic compromise
Early reperfusion (primary PCI)	Markedly improves outcomes

Conduction Abnormalities

Inferior MI is particularly prone to bradyarrhythmias and AV block, primarily via the Bezold-Jarisch reflex (enhanced vagal tone) and direct ischemia to the AV node (supplied by RCA).

Feature	Inferior MI	Anterior MI
Level of AV block	Supra-Hisian (at AV node) in ~90%	Infra-Hisian (His bundle, bundle branches)
Escape rhythm	Narrow complex, rate 40-60 bpm	Wide complex, unstable
Prognosis	Usually reversible after reperfusion	Worse prognosis, high mortality
Temporary pacing	Often NOT required; pharmacologic therapy usually effective	Typically indicated
AV block incidence	More common than anterior MI	Less common but more dangerous

AV block occurs transiently in 10-25% of all acute MI patients; it is more frequent with inferior MI.

Harrison's Principles of Internal Medicine 22E, pp. 343-345
Fuster and Hurst's The Heart 15th Ed.

Early sinus bradycardia in inferior MI is usually vagally mediated and self-limiting.

Posterior Extension

ST depression in leads V1-V3 during inferior MI can represent:

Reciprocal changes from inferior STEMI
Posterior extension (true posterior MI)
Simultaneous anterior ischemia

Patients with inferior MI who also have posterior extension (tall R waves in V1-V2, ST depression V1-V3, or ST elevation in posterior leads V7-V9) have larger infarct zones, lower EF, and higher morbidity/mortality.

To detect posterior MI: add leads V7-V9 (look for ST elevation ≥0.5 mm).

Complications Summary

Complication	Notes
RV infarction	~30% of inferior MIs; highest risk subgroup
AV block / bradycardia	Common; usually reversible if supra-Hisian
Posterior extension	~15-20% of inferior MIs
Papillary muscle dysfunction / MR	Posterior papillary muscle supplied by RCA; at risk
Cardiogenic shock	Less common than anterior MI

Key Pearls

Always obtain right-sided precordial leads (V4R) in every patient with inferior STEMI - do it within the first 24 hours.
III > II ST elevation = RCA culprit; II ≥ III = think LCx
Never give nitrates or diuretics before excluding RV infarction
AV block in inferior MI is generally benign and reversible; no pacing needed in most cases
Q waves in inferior MI often regress (unlike anterior MI where they persist)

Sources: ROSEN's Emergency Medicine; Goldman-Cecil Medicine; Fuster and Hurst's The Heart, 15th Ed.; Harrison's Principles of Internal Medicine 22E

How to use norad

Asking for Preferences

Reading File

Finding Sources

Searching PubMed

"norepinephrine"[MeSH Terms] AND "shock, septic"[MeSH Terms]

Reading File

Finding Sources

Reading File

I now have comprehensive data. Here is the full clinical guide:

Noradrenaline (Norepinephrine) - Clinical Guide

Mechanism of Action

Noradrenaline is a catecholamine with predominant alpha-1 (α1) adrenergic activity and moderate beta-1 (β1) activity. It has minimal beta-2 effect.

Receptor	Effect	Clinical result
α1 (dominant)	Vasoconstriction - arteries and veins	↑ SVR, ↑ MAP, ↑ BP
β1	Positive inotropy	↑ Cardiac output
Baroreceptor reflex	Vagal stimulation from rising BP	Reflex bradycardia (offsets direct cardiac effects)

The net cardiovascular result is a significant rise in blood pressure driven primarily by increased vascular resistance, with relatively little change in heart rate.

Lippincott Pharmacology, p. 231

Indications

Septic shock - first-line vasopressor (preferred over dopamine)
Distributive shock of any cause (anaphylactic, neurogenic, post-cardiac arrest)
Cardiogenic shock (adjunct, to maintain perfusion pressure)
Hepatorenal syndrome (HRS type 1) - used with midodrine/octreotide or albumin
Hypotension refractory to fluid resuscitation

Norepinephrine is the preferred first-line vasopressor in septic shock - it is slightly better than dopamine for mortality and carries a significantly lower rate of arrhythmias (especially AF).

Goldman-Cecil Medicine, p. 3618

Dosing

Adult

Indication	Starting dose	Titration	Range
Septic/distributive shock	8-12 mcg/min IV infusion	Titrate to MAP ≥65 mmHg	2-4 mcg/min maintenance
Septic shock (weight-based)	0.02-0.05 mcg/kg/min	Every 5-10 min increments	0.01-1.0 mcg/kg/min
Toxin-induced shock	0.5 mcg/kg/min max

Paediatric

Parameter	Detail
Starting dose	0.05-0.1 mcg/kg/min IV infusion
Titration	Titrate to effect
Maximum dose	2 mcg/kg/min

Note: Paediatric doses are in mcg/kg/min; adult doses are traditionally in mcg/min

Harriet Lane Handbook, p. 1268
Tintinalli's Emergency Medicine

Preparation / Administration

Route: Continuous IV infusion ONLY - never bolus or IM
Preferred access: Central venous line (CVC) strongly preferred due to risk of tissue necrosis from extravasation
Can be given peripherally in emergencies, but must monitor closely for extravasation
Half-life: Very short - duration of action is 1-2 minutes after stopping infusion (rapidly metabolized by MAO and COMT)
Dilution options: Pre-mixed concentrations available: 16 mcg/mL, 32 mcg/mL, or 64 mcg/mL in D5W or normal saline

MAP Target

Standard target: MAP ≥ 65 mmHg in most patients
A target of 65-70 mmHg is as effective as 80-85 mmHg (no mortality benefit from higher targets)
Titrate up or down every 5-10 minutes based on hemodynamic response

Add-on Therapy

When norepinephrine alone is insufficient, the following can be added:

Agent	Dose	Role
Vasopressin	0.01-0.03 U/min (max 0.03 U/min)	Norepinephrine-sparing; second-line
Dobutamine	2-20 mcg/kg/min	Add if poor cardiac contractility
Epinephrine	0.2 mcg/kg/min (instead of norad + dobutamine)	Equivalent outcomes, simpler
Angiotensin II	20 ng/kg/min, up to 200 ng/kg/min	Reduces norepinephrine requirements

Contraindications / Cautions

Situation	Note
Hypovolemia	Relative contraindication - correct volume first; use as emergency bridge only
Peripheral vein access	Avoid if possible due to extravasation risk
Mesenteric/renal ischemia	Monitor urine output and signs of gut ischemia

Adverse Effects

Effect	Detail
Hypertension	If over-titrated
Reflex bradycardia	From baroreceptor activation
Arrhythmias	Less than dopamine, but still possible
Tissue necrosis	From extravasation - most feared local complication
Organ ischemia	Renal, mesenteric, peripheral (from excess vasoconstriction)
Uterine contractions	Caution in pregnancy

Extravasation Management

If noradrenaline leaks into surrounding tissues:

Stop infusion at that site immediately
Inject phentolamine 5-10 mg intradermally into the affected area (alpha-blocker - reverses local vasoconstriction)
Alternatives: intradermal terbutaline or topical nitroglycerin
Treat promptly - tissue necrosis can be severe

Lippincott Pharmacology; Roberts and Hedges' Clinical Procedures in Emergency Medicine

Recent Evidence

Recent meta-analyses (2024-2025) support early initiation of norepinephrine in septic shock:

Ahn et al. 2024, Chest - Early vs. late NE administration: earlier initiation associated with improved outcomes (PMID 38972348)
Shi et al. 2025, Crit Care - Updated systematic review and meta-analysis with trial sequential analysis confirms benefit of early NE in septic shock (PMID 40329359)

Quick Summary Card

Parameter	Value
Drug class	Catecholamine vasopressor
Receptors	α1 >> β1
Route	IV infusion only
Adult start	8-12 mcg/min or 0.02-0.05 mcg/kg/min
Paediatric start	0.05-0.1 mcg/kg/min
Target	MAP ≥65 mmHg
Preferred access	Central line
1st line for	Septic shock
Extravasation Rx	Phentolamine

Use by peripheral line for adult in shock

Finding Sources

Searching PubMed

"norepinephrine" AND "peripheral" AND "vasopressor"

Searching the Web

peripheral norepinephrine infusion safety shock guidelines concentration duration 2024

Reading Article

PMID: 41838001

Reading Article

PMID: 39079823

Reading File

Excellent - I now have authoritative, current evidence from a 2026 JAMA Network Open meta-analysis and a 2025 systematic review. Here is the complete answer:

Peripheral IV Noradrenaline in Adult Shock

Is It Safe?

Yes - peripheral noradrenaline (pNA) is a safe and accepted practice for short-term use, particularly during early resuscitation when central access is not yet established.

The largest evidence to date:

ZhangJian et al. JAMA Network Open, 2026 (49 studies, 33,060 catheters): Minor adverse event rate for norepinephrine via short peripheral IV = only 2.6%. Only 1 case of tissue necrosis was reported across 29,596 short PIV catheters. CVC placement was avoided in 59.7% of cases. (PMID 41838001)
Fernández-Ginés et al. Farm Hosp, 2025 (83 studies): Peripheral NA is a "safe and beneficial option in early resuscitation" provided specific guidelines are followed. (PMID 39079823)

Key insight from the 2026 meta-analysis: It is specifically short PIV catheters that carry the lowest risk. Midline catheters had a 1.4% rate of venous thromboembolism - avoid midlines for vasopressors.

Step-by-Step Protocol for Peripheral Noradrenaline

1. Site Selection

Criteria	Detail
Best site	Antecubital fossa (AC) - large vein, proximal, less risk
Acceptable alternative	External jugular vein
Avoid	Hand, wrist, foot veins - distal, poor flow, high necrosis risk
Catheter gauge	18G or 20G (larger bore = better flow, lower extravasation risk)
Catheter type	Short peripheral IV only - NOT midline catheters

2. Confirm Line Patency Before Starting

Blood aspiration test: Aspirate blood freely to confirm intravascular position
Flush with 5-10 mL normal saline - no resistance, no swelling, no pain

3. Concentration

Route	Recommended concentration
Peripheral	8 mg/250 mL = 32 mcg/mL (standard)
Also acceptable peripheral	4 mg/250 mL = 16 mcg/mL (lower concentration, lower risk)
Central line	Higher concentrations acceptable

Critical rule: Peripheral and central concentrations are NOT interchangeable - always clearly label the bag. Complications are dose-dependent: complication rate 12% vs 2% if dose exceeds 0.13 mcg/kg/min or concentration exceeds 22.3 mcg/mL.

4. Dosing

Parameter	Value
Starting dose	0.05 mcg/kg/min
Maximum peripheral dose	0.15 mcg/kg/min (Gloucester NHS guideline) OR 20 mcg/min (VCU protocol)
Maximum peripheral dose (ROSEN's)	0.5 mcg/kg/min (as bridge to CVC)
Target	MAP ≥ 65 mmHg

5. Duration Limit

Guideline	Max duration
Gloucester NHS Critical Care	≤ 48 hours
VCU Protocol	≤ 4 hours then reassess
General principle	Use as a bridge - place CVC as early as possible

6. Monitoring (Mandatory)

Nurse must inspect the IV site:

Every 1-2 hours - inspect for early extravasation signs
Monitor for:

Sign	Meaning
Skin pallor at/around site	Early extravasation
Acrocyanosis (bluish discoloration)	Vasoconstriction - extravasation
Swelling / firmness	Fluid tracking into tissue
Dermal sloughing	Late sign - necrosis starting
Pain at site	Patient report

What NOT to Do

Avoid	Reason
Y-site co-infusion with other drugs	Risk of inadvertent NE bolus from line flush
Distal IV sites (hand, foot)	High necrosis risk
Midline catheters	High VTE risk (1.4%)
Abrupt discontinuation	Flush line with NS at same rate first to avoid hemodynamic collapse
Forgetting to insert CVC	Peripheral is a bridge only

On Stopping / Switching to Central Line

Place CVC (internal jugular, subclavian, or femoral) as soon as practically possible
When transitioning: start the central infusion first, then wean off peripheral
When stopping peripheral NE: flush the cannula with 0.9% saline at the same rate as the NE was running (prevents bolus effect)

Extravasation Management

If you see signs of extravasation:

Stop the infusion immediately at that site
Leave cannula in place briefly - aspirate as much drug as possible
Restart via a different limb/site
Treat the affected area:
- First line: Intradermal/subcutaneous phentolamine 5-10 mg diluted in saline, injected around the area
- Alternatives: Topical nitroglycerin 2% paste applied to the area, OR subcutaneous terbutaline (beta-2 agonist causes local vasodilation)
Document and monitor

Summary Card

Parameter	Value
Site	Antecubital fossa preferred
Gauge	18G or 20G
Confirm patency	Blood aspirate + 5-10 mL saline flush
Concentration	32 mcg/mL (or 16 mcg/mL)
Start dose	0.05 mcg/kg/min
Max dose	0.15-0.5 mcg/kg/min
Duration	Bridge to CVC; max 48h
Monitor	Every 1-2 hours, inspect site
No Y-site co-infusion	Yes
Extravasation Rx	Phentolamine first, topical GTN or terbutaline as alternatives

The evidence is now clear: short peripheral IV noradrenaline is reasonably safe at low-to-moderate doses with vigilant monitoring and should no longer be withheld in emergencies while awaiting CVC placement.

Dose in mg/ml from peripheral line for 60 kg with concentration 4mg/250ml

This is a straightforward calculation — no tools needed.

Noradrenaline Infusion Calculation

Patient: 60 kg | Concentration: 4 mg / 250 mL

Step 1 — Concentration in mcg/mL

$$\frac{4\ mg}{250\ mL} = 0.016\ mg/mL = \mathbf{16\ mcg/mL}$$

Step 2 — Dose range in mcg/kg/min → mL/hr

Standard peripheral dose range: 0.05 to 0.15 mcg/kg/min

Dose (mcg/kg/min)	mcg/min (×60 kg)	mcg/hr (×60)	mL/hr (÷16 mcg/mL)
0.05 (start)	3 mcg/min	180 mcg/hr	11.25 mL/hr
0.08	4.8 mcg/min	288 mcg/hr	18 mL/hr
0.10	6 mcg/min	360 mcg/hr	22.5 mL/hr
0.15 (max peripheral)	9 mcg/min	540 mcg/hr	33.75 mL/hr

Step 3 — Formula to use at bedside

$$\text{mL/hr} = \frac{\text{Dose (mcg/kg/min)} \times 60\ kg \times 60}{\text{16 mcg/mL}}$$

Or simplified:

$$\text{mL/hr} = \text{Dose (mcg/kg/min)} \times 225$$

(for this patient at this concentration)

Example: To run at 0.1 mcg/kg/min → 0.1 × 225 = 22.5 mL/hr

Quick Reference

Start at	11 mL/hr
Titrate up by ~3-4 mL/hr every 5-10 min
Max peripheral	34 mL/hr
Target	MAP ≥ 65 mmHg

Reminder: 4 mg/250 mL (16 mcg/mL) is the lower/safer concentration - appropriate for peripheral line use. Insert central line as soon as possible.

This is a shared conversation. Sign in to Orris to start your own chat.